- Home
- STKE vs IMMX Comparison
STKE vs IMMX Comparison
Compare STKE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKE
- IMMX
- Stock Information
- Founded
- STKE 2002
- IMMX 2014
- Country
- STKE Canada
- IMMX United States
- Employees
- STKE N/A
- IMMX N/A
- Industry
- STKE
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- STKE
- IMMX Health Care
- Exchange
- STKE Nasdaq
- IMMX Nasdaq
- Market Cap
- STKE 95.8M
- IMMX 82.6M
- IPO Year
- STKE N/A
- IMMX 2021
- Fundamental
- Price
- STKE $3.78
- IMMX $3.48
- Analyst Decision
- STKE
- IMMX Strong Buy
- Analyst Count
- STKE 0
- IMMX 1
- Target Price
- STKE N/A
- IMMX $8.00
- AVG Volume (30 Days)
- STKE 807.3K
- IMMX 702.9K
- Earning Date
- STKE 01-29-2026
- IMMX 11-11-2025
- Dividend Yield
- STKE N/A
- IMMX N/A
- EPS Growth
- STKE N/A
- IMMX N/A
- EPS
- STKE N/A
- IMMX N/A
- Revenue
- STKE $14,342,517.00
- IMMX N/A
- Revenue This Year
- STKE $43.15
- IMMX N/A
- Revenue Next Year
- STKE $39.60
- IMMX N/A
- P/E Ratio
- STKE N/A
- IMMX N/A
- Revenue Growth
- STKE N/A
- IMMX N/A
- 52 Week Low
- STKE $3.06
- IMMX $1.34
- 52 Week High
- STKE $34.32
- IMMX $3.71
- Technical
- Relative Strength Index (RSI)
- STKE N/A
- IMMX 73.92
- Support Level
- STKE N/A
- IMMX $2.31
- Resistance Level
- STKE N/A
- IMMX $3.71
- Average True Range (ATR)
- STKE 0.00
- IMMX 0.30
- MACD
- STKE 0.00
- IMMX 0.09
- Stochastic Oscillator
- STKE 0.00
- IMMX 80.92
About STKE Sol Strategies Inc. Common Shares
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.